Dendritic systems in drug delivery applications

被引:30
作者
Jain, Narendra K. [1 ]
Asthana, Abhay [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Pharmaceut Res Lab, Sagar 470003, India
关键词
biocompatibility; biopharmaceutical issues; covalent interaction; dendrimers; drug delivery; encapsulation; nanoconstructs; routes of administration;
D O I
10.1517/17425247.4.5.495
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The design of well-defined particulate carrier systems with controlled size, shapes and physicochemical characteristics is becoming a focal point in the field of biomedicine and drug delivery. Dendrimers are one of the emerging technologies of recent times and have served as a unique platform to achieve the development as novel drug delivery scaffolds. Dendrimers may be engineered to meet the specific needs of biologically active agents, which can either be encapsulated within dendrimers or chemically attached to these units. The large number of active functional groups on the surface of dendrimers allows them to be meticulously tailored and to act as nano-scaffolds or nano-containers of various categories of drugs. The architecture of modified dendrimers has posed a challenge to drug delivery, in particular with respect to their in vivo metabolic fate. The drug delivery applications of dendrimers presented in this article provide an insight of their potential and substantiate the major roles for the future of these nanoconstructs.
引用
收藏
页码:495 / 512
页数:18
相关论文
共 102 条
[1]  
[Anonymous], 1993, ALDRICHIM ACTA
[2]   Synthesis of glycodendrimers by modification of poly(propylene imine) dendrimers [J].
Ashton, PR ;
Boyd, SE ;
Brown, CL ;
Nepogodiev, SA ;
Meijer, EW ;
Peerlings, HWI ;
Stoddart, JF .
CHEMISTRY-A EUROPEAN JOURNAL, 1997, 3 (06) :974-984
[3]  
ASTHANA A, 2005, AM ASS PHARM SCI TEC, V67, pE536
[4]   Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives [J].
Beezer, AE ;
King, ASH ;
Martin, IK ;
Mitchell, JC ;
Twyman, LJ ;
Wain, CF .
TETRAHEDRON, 2003, 59 (22) :3873-3880
[5]  
Bernstein DI, 2003, ANTIVIR RES, V57, pA66
[6]   PEGylated peptide-based dendritic nanoparticulate systems for delivery of artemether [J].
Bhadra, D ;
Bhadra, S ;
Jain, NK .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2005, 15 (01) :65-73
[7]   A PEGylated dendritic nanoparticulate carrier of fluorouracil [J].
Bhadra, D ;
Bhadra, S ;
Jain, S ;
Jain, NK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) :111-124
[8]   Molecular modeling of polyamidoamine (PAMAM) Starburst™ dendrimers [J].
Bhalgat, MK ;
Roberts, JC .
EUROPEAN POLYMER JOURNAL, 2000, 36 (03) :647-651
[9]   About dendrimers: Structure, physical properties, and applications [J].
Bosman, AW ;
Janssen, HM ;
Meijer, EW .
CHEMICAL REVIEWS, 1999, 99 (07) :1665-1688
[10]  
BUHLEIER E, 1978, SYNTHESIS-STUTTGART, P155